Press Releases | Alexion Pharmaceuticals, Inc

About Alexion
Patient Focus
Products
Research & Development
Responsibility
Careers
Select a Country
- North America
  - Canada
  - USA
- Latin America
  - Argentina
  - Brazil
  - Colombia
  - Mexico
- Europe, the Middle East & Africa
  - Alexion Europe
  - Belgium
  - Denmark
  - France
  - Germany
  - Ireland
  - Italy
  - Netherlands
  - Norway
  - Russia
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - UAE
  - UK
- Asia Pacific
  - Australia
  - China
  - India
  - Japan
Investors
News
Contact

Home
»
Newsroom
»
Press Releases

Press Releases

All News Releases

PNH Patients Treated with Soliris™ Experienced Dramatic Reduction in Blood Clots During Clinical Trials
August 20, 2007
HTML PDF
Alexion Reports Second Quarter 2007 Results
July 25, 2007
HTML PDF
Alexion to Present At Cowen and Company 7th Annual Global Health Care Conference
November 3, 2006
HTML PDF
Alexion Pharmaceuticals Reports Third Quarter 2006 Results
November 1, 2006
HTML PDF
Alexion Pharmaceuticals Invites You to Participate in its Third Quarter Results Conference Call and Web Cast
October 13, 2006
HTML PDF
Alexion Submits Market Authorization Application for Soliris(TM) (eculizumab) in the Treatment of Paroxysmal Nocturnal Hemoglobinuria to the European Medicines Agency
September 26, 2006
HTML PDF
Alexion Pharmaceuticals Submits Biologics License Application for Soliris(TM) (eculizumab)
September 20, 2006
HTML PDF
Soliris(TM) (eculizumab) Demonstrates Significant Improvement in PNH Study
September 20, 2006
HTML PDF
Alexion To Present At UBS Global Life Sciences Conference
September 18, 2006
HTML PDF
Alexion to Present at Bear Stearns healthcare Conference
September 5, 2006
HTML PDF